Cargando…

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion

Background: Smoking is the leading cause of preventable death worldwide. It is responsible for several types of cancer, cardiovascular diseases, and diseases of the reproductive system, among others. Therefore, advances in research are increasingly necessary in order to make smoking cessation treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomaz, Paulo Roberto Xavier, Gonçalves, Thuane Sales, Santos, Juliana Rocha, Scholz, Jaqueline, Abe, Tânia Ogawa, Gaya, Patrícia Viviane, Figueiredo, Eduardo Costa, de Faria, Henrique Dipe, Martins, Isarita, Pego, Ana Miguel Fonseca, Bismara, Beatriz Aparecida, Yonamine, Maurício, Pereira, Alexandre Costa, Santos, Paulo Caleb Júnior Lima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354088/ https://www.ncbi.nlm.nih.gov/pubmed/35935834 http://dx.doi.org/10.3389/fphar.2022.900112

Ejemplares similares

Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020)

Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021)

Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2018)

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
por: Rocha Santos, Juliana, et al.
Publicado: (2015)

Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials
por: King, David P, et al.
Publicado: (2012)

A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
por: Benli, Ali Ramazan, et al.
Publicado: (2017)

Combination Varenicline/Bupropion Treatment Benefits Highly Dependent Smokers in an Adaptive Smoking Cessation Paradigm
por: Rose, Jed E, et al.
Publicado: (2017)

Influence of smoking cessation drugs on blood pressure and heart rate in patients with cardiovascular disease or high risk score: real life setting
por: Silva, André Pacheco, et al.
Publicado: (2016)

Could APO-varenicline and cytisine be solutions for the shortage of varenicline in Brazil?
por: Corrêa, Paulo César Rodrigues Pinto, et al.
Publicado: (2023)

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors
por: Beard, Emma, et al.
Publicado: (2021)

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo
por: Gonzales, David, et al.
Publicado: (2010)

Efficacy of varenicline versus bupropion for smoking cessation: A systematic review and meta-analysis of randomized controlled trials
por: Patel, Ashish R., et al.
Publicado: (2023)

Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
por: Kotz, Daniel, et al.
Publicado: (2014)

General Practitioners' views on the provision of nicotine replacement therapy and bupropion
por: McEwen, Andy, et al.
Publicado: (2001)

A case of hypomania during nicotine cessation treatment with bupropion
por: Giasson-Gariépy, Karine, et al.
Publicado: (2013)

Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice
por: Stapleton, John, et al.
Publicado: (2013)

Effects of aging on the effectiveness of smoking cessation medication
por: Scholz, Jaqueline, et al.
Publicado: (2016)

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial
por: Zawertailo, Laurie, et al.
Publicado: (2018)

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011)

Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial
por: Hajek, Peter, et al.
Publicado: (2013)

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)

A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
por: Narayan, A. Lakshmi, et al.
Publicado: (2015)

2532: Predictive metabolism studies of varenicline and implications of its metabolites in nicotine addiction
por: Thompson, Keeshaloy, et al.
Publicado: (2018)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Stereoselective Metabolism of Bupropion to OH-bupropion, Threohydrobupropion, Erythrohydrobupropion, and 4′-OH-bupropion in vitro
por: Sager, Jennifer E., et al.
Publicado: (2016)

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat
por: Garcia-Rivas, Vernon, et al.
Publicado: (2019)

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
por: Ramon, Josep M, et al.
Publicado: (2014)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial
por: Tulloch, Heather E., et al.
Publicado: (2016)

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial
por: Davis, James M., et al.
Publicado: (2023)

Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α(4)β(2)-receptor partial agonist varenicline
por: Batsikadze, G., et al.
Publicado: (2017)

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
por: Carlson, Eric C., et al.
Publicado: (2023)

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
por: Wouda, Jelte A., et al.
Publicado: (2011)

Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014)

Hyponatremia Associated with Bupropion
por: Kim, Chang Seong, et al.
Publicado: (2011)

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
por: Aubin, H-J, et al.
Publicado: (2008)

Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens
por: Feduccia, A A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4hi8k173lbu54lk5c8bt7b3ps7